Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure

Details for Australian Patent Application No. 2002352625 (hide)

Owner ELI LILLY AND COMPANY

Inventors Yang, Charles Renkin; Bymaster, Franklin Porter; Gehlert, Donald Richard; Mckinzie, David Lee

Agent Spruson & Ferguson

Pub. Number AU-A-2002352625

PCT Number PCT/US02/36132

PCT Pub. Number WO2003/049724

Priority 60/339,174 11.12.01 US

Filing date 27 November 2002

Wipo publication date 23 June 2003

International Classifications

A61K 031/00

A61P 025/28 Drugs for disorders of the nervous system

A61K 031/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/339,174 11.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002352625

26 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352626-UNIVERSAL HIGH EFFICIENCY POWER CONVERTER

2002352624-ADAPTER FOR A TELEPHONE HOLDER PERTAINING TO A HANDSFREE DEVICE